LONDON, June 15, 2023 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. With this ...

Hikma is introducing dobutamine injection, in a 250 mg/20 ml vial. With this launch, Hikma’s growing U.S. portfolio of sterile injectable medicines now exceeds 150 products spanning a wide range of ...

Hospira announced a nationwide recall for one lot of Dobutamine Injection, 250mg, 20mL, single-dose fliptop vial. This recall was following a customer report of discolored solution. A closer ...

The National Pharmaceutical Pricing Authority (NPPA) has proposed to bring down the ceiling price of anti-cardiac drug dobutamine injection 50 mg by around 81 per cent and snake venom antiserum by ...

Dobutamine (K .M. Dobutamine) is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock. It stimulates the heart muscle. The information provided on this page is ...

Tirofiban hydrochloride injection 0.05 mg/mL was stable for at least four hours at room temperature when combined 1:1 in glass containers with atropine sulfate, dobutamine, epinephrine hydrochloride, ...